Characterization of novel potent and selective anaplastic lymphoma kinase (ALK) inhibitors.
C. M. Lovly
No relevant relationships to disclose
E. de Stanchina
No relevant relationships to disclose
H. Chen
No relevant relationships to disclose
C. Liang
Employment or Leadership Position - Xcovery
Stock Ownership - Xcovery
W. Pao
Research Funding - Xcovery